Table 1 Baseline characteristics
From: Health care utilization in patients with gout: a prospective multicenter cohort study
Total Cohort N = 186 | Los Angeles N = 112 | Birmingham N = 74 | |
|---|---|---|---|
Age, Mean (SD) | 64.6 (10.9) | 65.7 (11.2) | 62.9 (10.2) |
Gender, N (%) | |||
Male | 182 (97.85) | 109 (97.32) | 73 (98.65) |
Female | 4 (2.15) | 3 (2.68) | 1 (1.35) |
Race, N (%) | |||
American Indian | 1 (0.54) | 1 (0.89) | 0 (0) |
Asian | 6 (3.23) | 6 (5.36) | 0 (0) |
Native Hawaiian or other Pacific Islander | 1 (0.54) | 1 (0.89) | 0 (0) |
Black or African American | 60 (32.26) | 17 (15.18) | 43 (58.11) |
White | 107 (57.53) | 76 (67.86) | 31 (41.89) |
Other | 11 (5.91) | 11 (9.82) | 0 (0) |
Ethnicity, N (%) | |||
Hispanic or Latino | 21 (13.04) | 20 (18.69) | 1 (1.85) |
Not Hispanic or Latino | 140 (86.96) | 87 (81.31) | 53 (98.15) |
Missing | 25 | 5 | 20 |
Education, N (%) | |||
Grades 9 to 11 | 11 (5.98) | 8 (7.27) | 3 (4.05) |
High school graduate | 35 (19.02) | 17 (15.45) | 18 (24.32) |
Some college | 88 (47.83) | 54 (49.09) | 34 (45.95) |
College graduate | 30 (16.30) | 13 (11.82) | 17 (22.97) |
Beyond college | 20 (10.87) | 18 (16.36) | 2 (2.70) |
Tophi Diagnosed, N (%) | |||
No | 136 (78.61) | 74 (67.89) | 62 (96.88) |
Yes | 37 (21.39) | 35 (32.11) | 2 (3.13) |
Missing | 13 | 3 | 10 |
Serum Uric Acid, Mean (SD) [Median (IQR)] | 8.3 (3.4) [7.9 (3.5)] | 7.5 (1.9) [7.5 (3.0)] | 10.1 (5.1) [9.7 (8.2)] |
Severity of Gout, Mean (SD) | |||
Patient Assessment (GAQ) | 5.7 (3.1) [6.0 (5.0)] | 6.1 (3.1) [6.5 (4.5)] | 5.2 (3.1) [4.0 (5.0)] |
Physician Assessment | 3.1 (2.7) [3.0 (4.0)] | 3.0 (2.5) [3.0 (3.5)] | 3.3 (2.9) [2.8 (5.0)] |
Charlson Comorbidities, Mean (SD) | 5.14 (2.74) | 5.36 (3.02) | 4.75 (2.16) |